Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
Bristol-Myers Squibb is currently enjoying a diversified asset portfolio whose sales are expected to keep growing going forward. The stock's valuation is hard to justify even when accounting for patent expirations potentially hurting revenues post-2025. The company is a free cash ...
Connect Biopharma has filed proposed terms for its U.S. IPO. The firm is developing antibody-based treatments for inflammatory diseases. While the IPO isn't cheap, CNTB has seen promising Phase 2 trial efficacy results and the IPO is worth a close look for life science investors. ...
Evofem recently launched the first new non-hormonal birth control option in decades. Clinical efficacy falls short of the copper IUD, PARAGARD, but that device I believe may come with significant side effects. A trend in birth control centered on the woman's quality of life (safet...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with this event. For further details see: Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow
David Abrams’ 13F portfolio value increased this quarter from $3.16B to $3.55B. The number of positions decreased from 19 to 17. Abrams Capital Management dropped Franklin Resources and Akebia Therapeutics during the quarter. The top three positions are Lithia Motors, Trans...
Teva Pharmaceutical Industries Limited (TEVA) Q4, 2020 Earnings Conference Call February 10, 2021 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President, Head Investor Relations Kåre Schultz - President & Chief Executive Officer Eli Kalif - Chief Financial Officer Bren...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2020 Q4 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2020 Q4 - Results - Earnings Call Presentation
Israel is a developed country, and part of the OECD, yet overlooked by many investors. The Israeli economy is recovering relatively fast from Covid and is well diversified. After lagging the American markets despite faster growth, it might be a good time to look at Israel. ITEQ is...
Teva Pharmaceutical Industries Limited (TEVA) 39th Annual JP Morgan Healthcare Conference January 12, 2021 10:00 A.M. ET Company Participants Kåre Schultz - President and Chief Executive Officer Eli Kalif - EVP and CFO Conference Call Participants Chris Schott - J.P. Morgan Presentation ...
Horizon Therapeutics has morphed into a biotech star due to its new compound Tepezza. Tepezza is approved for the treatment of thyroid eye disease otherwise known as TED. Tepezza is a star generating faster growth as widespread adoption has occurred at a pace faster than expected....
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: